Just In
- 3 hrs ago Met Gala 2024: Date, Theme, Venue, Guest List, All You Need To Know About The Fashion Event
- 9 hrs ago Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic
- 11 hrs ago Sonam Kapoor Stuns In A Huisang Zhang Skirt Set, A Skirt-Top Style Guide From The OG Fashionista!
- 14 hrs ago Thrissur Pooram 2024: Date, Time, History, Significance, And Celebrations Related To Kerala's Rich Traditions
Don't Miss
- News TDP Candidate Dr G Laxmi Pauses Lok Sabha Election Campaign To Perform Caesarean
- Sports IPL Points Table 2024 After Today's Match, LSG vs CSK: Check Indian Super League Standings And Results On April 19
- Education Exam Pressure Does Not Exist; Studying Punctually is Crucial; Says Aditi, the PSEB 2024 Topper
- Movies When Karan Johar Revealed Sara Ali Khan And Janhvi Kapoor Once Dated Siblings On KWK 7, Guess Who?
- Finance Reliance, ONGC, Tata, Adanis: Energy Stocks Didn't Get The Memo Of Bears, Up 12% In 30-Days; 10 Stocks To BUY
- Automobiles Suzuki Swift Hatchback Scores 4 Star Safety Rating At JNCAP – ADAS, New Engine & More
- Technology Dell Introduces AI-Powered Laptops and Mobile Workstations for Enterprises in India
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
Cipla, DNDi Launch 4-In-1 Antiretroviral Treatment For Children With HIV
Homegrown pharma major Cipla Ltd and its partner Drugs for Neglected Diseases initiative (DNDi) on Tuesday announced the launch of a 4-in-1 antiretroviral treatment for children living with HIV in South Africa.
South African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine, lopinavir, and ritonavir that is specifically designed for infants and young children with HIV, Cipla said in a regulatory filing.
This combination treatment has been developed by Cipla and not-for-profit DNDi, it added. The new formulation does not require refrigeration. It has a sweet taste and is easy to administer to infants and children of different weights and ages, a major improvement for both children and their caregivers over previously available formulations, the company said.
"This approval has come at an important time when so many children are suffering from HIV at such a young age. We will continue in our endeavour to enable access to life-saving solutions for all," Cipla Managing Director and Global CEO Umang Vohra said.
DNDi Head of HIV Irene Mukui said it is highly significant that this first regulatory approval of the 4-in-1 formulation is from a country that has a high burden of HIV among children.
"SAHPRA's accelerated review is notable and encouraging for other high-burden countries, and we acknowledge this show of commitment by the South African authorities. Now, it is our hope that all the necessary steps will be taken - first in South Africa and then in other countries - to ensure the broadest possible access to this optimal formulation for young children who need it," Mukui added.
Until recently, Cipla said the only WHO-recommended lopinavir-based treatment available for babies and very young children in South Africa consisted of a syrup that contained 40 per cent alcohol and required refrigeration.
Caregivers struggled to give this bitter-tasting formulation to young children, leading to poor adherence. Caregivers without refrigeration had a very difficult time storing the formulations - sometimes burying them in the ground to keep them cold, it added.
South Africa has 2.38 lakh children under the age of 15 living with HIV - the highest in the world, the company said.
- astrologyWorld AIDS Day 2023: Messages, Slogans, Wishes And Quotes Of Hope, And Compassion
- healthWorld HIV/AIDS Day: Ancient AIDS Treatments: Did They Stand the Test of Time?
- healthWorld HIV/AIDS Day: What Is The Difference Between HIV and AIDS?
- healthWorld AIDS Day: 3 Not So Common Ways HIV Can Spread from Person to Person
- pregnancy parenting14 Children Infected With HIV, Hepatitis After Blood Transfusion In UP Hospital: How Did It Happen?
- healthSexual Diseases You Might Have Without Symptoms
- pulseZero Discrimination Day 2023: Date, Theme, And Why It Is Observed
- disorders cureWorld AIDS Day 2022: Can Kissing An HIV Positive Person Cause An HIV Infection?
- wellnessHIV Positive Patients In Haryana To Get Free Health Facilities Like Lab And Radiological Tests
- disorders cureNew Study Signals The Development Of Unique Genetic Treatment For HIV
- disorders cureOver 17 Lakh People Contracted HIV In India In Last 10 Years By Unprotected Sex: RTI Reply
- disorders cureFirst Woman Reported Cured Of HIV After Stem Cell Transplant, Know Details